Biliary fistula after treatment for hydatid disease of the liver: When to intervene

Table 1 Preoperative characteristics of patients with hydatid disease of the liver (mean ± SD)

	Bile fistula		P value
	Absent	Present
Age, yr	32.0	31.5	0.8
Gender (M/F)	179/57	38/8	0.3
Cholangitis	6 (3%)	24 (52%)	< 0.001
Albendazol treatment	118 (50%)	23 (50%)	0.7
AST (U/L)	221.0 ± 32.2	44.0 ± 36.0	0.5
ALT (U/L)	223.0 ± 41.2	44.0 ± 38.4	0.8
ALP (U/L)	40.0 ± 235.1	190.0 ± 167.3	0.02
GGT (U/L)	25.0 ± 71.7	151.0 ± 64.3	0.08
Total bilirubin (mg/dL)	0.9 ± 1.44	1.5 ± 3.0	0.05
White blood cell	8077.3 ± 2945.0	8802.2 ± 3222.7	0.1

AST: Aspartate aminotransferase; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; GGT: Gamma-glutamyltranspeptidase.